Quick Answer
Lexaria Bioscience Corp. reported Total Assets of $4.18 million for fiscal year 2025.
Lexaria Bioscience Corp. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $4.18M | -52.9% |
| 2024 | $8.87M | +187.5% |
| 2023 | $3.08M | -60.6% |
| 2022 | $7.83M | -41.0% |
| 2021 | $13.27M | +369.1% |
| 2020 | $2.83M | +5.7% |
| 2019 | $2.68M | +10.0% |
| 2018 | $2.43M | -15.0% |
| 2017 | $2.86M | +404.8% |
| 2016 | $566.6K | -20.4% |
| 2015 | $711.7K | -73.0% |
| 2014 | $2.64M | -26.3% |
| 2013 | $3.57M | -14.8% |
| 2012 | $4.19M | -3.4% |
| 2011 | $4.34M | +32.4% |
| 2010 | $3.28M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $6.05M | -38.2% | +44.9% |
| August 31, 2025 | $4.18M | -52.9% | -38.1% |
| May 31, 2025 | $6.74M | -32.7% | -22.3% |
| February 28, 2025 | $8.68M | +36.6% | -11.4% |
| November 30, 2024 | $9.79M | +170.0% | +10.4% |
| August 31, 2024 | $8.87M | +187.5% | -11.5% |
| May 31, 2024 | $10.02M | +91.2% | +57.7% |
| February 29, 2024 | $6.35M | +30.8% | +75.1% |
- Lexaria Bioscience Corp. showed a decrease of -52.9% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Lexaria Bioscience Corp.’s total assets has grown by 27.4% (from $3.28 million to $4.18 million).
- The most recent figure is from Lexaria Bioscience Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: